Evidence map›Paper›PMID 29720392›Full record

ArticleG3 (Bethesda, Md.)2018

Activation of Self-Incompatibility Signaling in Transgenic

Masaya Yamamoto, Takeshi Nishio, June B Nasrallah

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Chloride Channel Family in the EuhalophyteInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Masaya YamamotoGraduate School of Agricultural Science, Tohoku University, Sendai, Miyagi 980-0845, Japan.
Takeshi NishioGraduate School of Agricultural Science, Tohoku University, Sendai, Miyagi 980-0845, Japan.
June B NasrallahSection of Plant Biology, School of Integrative Plant Science, Cornell University, Ithaca, NY 14853 jbn2@cornell.edu.ORCID 0000-0002-6267-8074
Cornell University · USTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Internalization of plasma membrane (PM)-localized ligand-activated receptor kinases and their trafficking to sorting endosomes have traditionally been viewed as functioning primarily in the down-regulation of receptor signaling, but are now considered to be also essential for signaling by some receptors. A major mechanism for internalization of PM proteins is clathrin-mediated endocytosis (CME). CME is mediated by the Adaptor Protein Complex 2 (AP2), which is involved in interaction of the AP2 μ-adaptin subunit with a tyrosine-based Yxxϕ motif located in the cytoplasmic domain of the cargo protein. In this study, we investigated the role of AP2-mediated CME for signaling by the S-locus receptor kinase (SRK), a protein localized in the PM of stigma epidermal cells, which, together with its pollen coat-localized S-locus cysteine-rich (SCR) ligand, functions in the self-incompatibility (SI) response of the Brassicaceae. Using

Indexed as

EndocytosisSelf-Incompatibility in Flowering PlantsSignal TransductionAdaptor Protein Complex 2Amino Acid MotifsAmino Acid SequenceArabidopsisClathrinCRISPR-Cas SystemsGene ExpressionGene TargetingMutationPlant ProteinsPlants, Genetically ModifiedPollinationProtein BindingAdaptor Protein Complex 2ClathrinPlant ProteinsAP2-complexArabidopsis thalianaendocytosisself-incompatibilityS-locus receptor kinase

Identifiers

PMID29720392
PMCPMC6027874
OpenAlexW2799331833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.